Effects of cetirizine on the delayed K+ currents in cardiac cells: Comparison with terfenadine

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 663-668

  Carmeliet, Edward ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Arrhythmia; Cetirizine; K+ current; Patch clamp; Single cardiac cell; Terfenadine; Torsade de pointes

Indexed keywords

CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; POTASSIUM ION; TERFENADINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; ENANTIOMER; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE CELL; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RABBIT;

ANIMALS; CETIRIZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART; HISTAMINE H1 ANTAGONISTS; ION CHANNEL GATING; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RABBITS; STEREOISOMERISM; TERFENADINE;

EID: 0031835115     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701879     Document Type: Article

References (29)

1. BERUL, C.I. & MORAD, M. (1995). Regulation of potassium channels by nonsedating antihistamines. Circulation. 91, 2220-2225.
2. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ. Res., 73, 379-385.
3. + current in cardiac myocytes by dofetilide. J. Pharmacol. Exp. Ther., 262, 809-817.
4. + current by almokalant in rabbit ventricular myocytes. Circ. Res., 73, 857-868.
5. COULIE, P., DELAERE, A., DE VOS, Ch., DONELLY, F. & RIHOUX, J.P. (1998). Non-sedating antihistamines and cardiac arrhythmias. The Lancet. 351, 451.
6. CRUMB, W.J., WIBLE, B., ARNOLD, D.J., PAYNE, J.P. & BROWN, A.M. (1995). Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated toxicity. Mol. Pharmacol., 47, 181-190.
7. DAVIES, A.J., HARINDRA, V., McEWAN, A. & GHOSE, R.R. (1989). Cardiotoxic effect with convulsions in terfenadine overdose. Br. Med. J., 298, 325.
8. HANRAHAN, J.P., CHOO, P.W., CARLSON, W., GREINEDER, D., FAICH, G.A. & PLATT, R. (1995). Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann. Epidemiol., 5, 201-209.
9. HEATH, B.M. & TERRAR, D.A. (1996). Separation of the components of the delayed rectifier potassium current using selective blockers of iKr and IKs in guinea-pig isolated ventricular myocytes. Exp. Physiol., 81, 587-603.
10. + current by dofetilide. Circ. Res., 72, 75-83.
11. + currents in nonfailing human hearts, subepicardial ventricular myocytes. Circulation, 92, 1179-1187.
12. LEYSEN, J.E., GOMMEREN, W., JANSSEN, P.F., SANZ, G., GILLARDIN, J.M., SCHOTTE, A. & JANSSEN, P.A. (1991). Antihistaminiques non-sédatifs et liaison aux récepteurs histaminiques-H1 centraux et périphériques. Allerg. Immunol. Paris, 23, 51-57.
13. LINDQUIST, M. & EDWARDS, I.R. (1997). Risks of non-sedating antihistamines. The Lancet, 349, 1322.
14. MOGUILEVSKY, N., VARSALONA, F., GUILLAUME, J.-P., NOYER, M., GILLARD, M.J., DALIERS, J.-P.H. & BOLLEN, A. (1995). Pharmacological and functional characterization of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells. J. Receptor Signal Transduction Res., 15, 91-102.
15. MORGANROTH, J., BROWN, A.M., CRITZ, S., CRUMB, W.J., KUNZE, D.L., LACERDA, A.E. & LOPEZ, H. (1993). Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event. Am. J. Cardiol., 72, 26b-31b.
16. PINNEY, S.P., KOLLER, B.S., FRANZ, M.R. & WOOSLEY, R.L. (1995). Terfenadine increases the QT interval in isolated guinea pig heart. J. Cardiovasc. Pharmacol., 25, 30-34.
17. + channel cloned from human heart. Mol. Pharmacol., 44, 1240-1245.
18. RODEN, D.M. (1993). Torsade de pointes. Clin-Cardiol., 16, 683-686.
19. + current. Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol., 96, 195-215.
20. 1-Receptor antagonists. Comparative tolerability and safety. Drug Safety, 10, 350-380.
21. SMITH, S.J. (1994). Cardiovascular toxicity of antihistamines. Otolaryngol. Head Neck Surg., 111, 348-354.
22. SNYDER, S.H. & SNOWMAN, A.M. (1987). Receptor effects of cetirizine. Ann. Allergy, 59, 4-8.
23. TER LAAK, A.M., DONNE OP DEN KELDER, G.M., BAST, A. & TIMMERMAN, H. (1993). Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study. Eur. J. Pharmacol., 232, 199-205.
24. VELDKAMP, M.W., VAN GINNEKEN, A.C., OPTHOF, T. & BOUMAN, L.N. (1995). Delayed rectifier channels in human ventricular myocytes. Circulation, 92, 3497-3504.
25. WILEY, J.F.D., GELBER, M.L., HENRETIG, K.M., WILEY, C.C., SANDHU, S. & LOISELLE, J. (1992). Cardiotoxic effects of astemizole overdose in children. J. Pediatr., 120, 799-802.
26. WOOSLEY, R.L. (1996). Cardiac actions of antihistamines. Annu. Rev. Pharmacol. Toxicol., 36, 233-252.
27. WOOSLEY, R.L., CHEN, Y., FREIMAN, J.P. & GILLIS, R.A. (1993). Mechanism of the cardiotoxic actions of terfenadine. J. Am. Med. Assoc., 269, 1532-1536.
28. WOOSLEY, R.L. & SALE, M. (1993). QT interval: a measure of drug action. Am. J. Cardiol., 72, 36b-43b.
29. YANG, T., PRAKASH, C., RODEN, D.M. & SNYDERS, D.J. (1995). Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br. J. Pharmacol., 115, 267-274.